Product Code: ETC089482 | Publication Date: Jun 2021 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
As concerns over infectious diseases and public health persist, the Antiparasitics Drugs market in Mexico assumes a critical role. This overview analyzes the market landscape, considering factors like the prevalence of parasitic infections, healthcare infrastructure, and regulatory frameworks. The demand for antiparasitic drugs is influenced by both human and veterinary applications, making it an essential component of the Mexican pharmaceutical industry.
The Mexico Antiparasitic Drugs market is witnessing a rise in demand driven by increasing awareness about parasitic infections and their impact on public health. The market is marked by a trend towards the development of novel antiparasitic drugs with enhanced efficacy and reduced side effects. With a focus on preventive healthcare, there is a growing inclination towards veterinary antiparasitic drugs, reflecting the importance of animal health in the overall ecosystem.
The antiparasitic drugs market in Mexico faces challenges due to the prevalence of parasitic infections and limited access to healthcare services in certain regions. While there is a growing demand for antiparasitic medications, particularly in rural areas with higher incidences of parasitic diseases, logistical challenges in distribution and affordability hinder market growth. Moreover, resistance to existing antiparasitic drugs poses a significant challenge, necessitating the development of novel therapeutic solutions.
The Mexican government oversees the antiparasitic drugs market through regulations aimed at ensuring veterinary product safety, efficacy, and responsible use. Policies govern the registration, manufacturing, importation, distribution, and usage of antiparasitic drugs for livestock and companion animals. Regulatory agencies establish standards for product quality, labeling, and dosage regimens to prevent parasitic infections and minimize drug residues in food products. Additionally, there are measures in place to monitor and regulate the sale of antiparasitic drugs to prevent misuse and promote sustainable parasite control strategies.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Antiparasitics Drugs Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Antiparasitics Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Antiparasitics Drugs Market - Industry Life Cycle |
3.4 Mexico Antiparasitics Drugs Market - Porter's Five Forces |
3.5 Mexico Antiparasitics Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.6 Mexico Antiparasitics Drugs Market Revenues & Volume Share, By Drug class, 2021 & 2031F |
3.7 Mexico Antiparasitics Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mexico Antiparasitics Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Mexico Antiparasitics Drugs Market Trends |
6 Mexico Antiparasitics Drugs Market, By Types |
6.1 Mexico Antiparasitics Drugs Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 Mexico Antiparasitics Drugs Market Revenues & Volume, By Route of Administration, 2018 - 2031F |
6.1.3 Mexico Antiparasitics Drugs Market Revenues & Volume, By Oral, 2018 - 2031F |
6.1.4 Mexico Antiparasitics Drugs Market Revenues & Volume, By Injectable, 2018 - 2031F |
6.1.5 Mexico Antiparasitics Drugs Market Revenues & Volume, By Topical, 2018 - 2031F |
6.2 Mexico Antiparasitics Drugs Market, By Drug class |
6.2.1 Overview and Analysis |
6.2.2 Mexico Antiparasitics Drugs Market Revenues & Volume, By Anthelmintics, 2018 - 2031F |
6.2.3 Mexico Antiparasitics Drugs Market Revenues & Volume, By Antiprotozoals, 2018 - 2031F |
6.2.4 Mexico Antiparasitics Drugs Market Revenues & Volume, By Others, 2018 - 2031F |
6.3 Mexico Antiparasitics Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Mexico Antiparasitics Drugs Market Revenues & Volume, By Hospital Pharmacies, 2018 - 2031F |
6.3.3 Mexico Antiparasitics Drugs Market Revenues & Volume, By Retail Pharmacies, 2018 - 2031F |
6.3.4 Mexico Antiparasitics Drugs Market Revenues & Volume, By Online Pharmacies, 2018 - 2031F |
7 Mexico Antiparasitics Drugs Market Import-Export Trade Statistics |
7.1 Mexico Antiparasitics Drugs Market Export to Major Countries |
7.2 Mexico Antiparasitics Drugs Market Imports from Major Countries |
8 Mexico Antiparasitics Drugs Market Key Performance Indicators |
9 Mexico Antiparasitics Drugs Market - Opportunity Assessment |
9.1 Mexico Antiparasitics Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.2 Mexico Antiparasitics Drugs Market Opportunity Assessment, By Drug class, 2021 & 2031F |
9.3 Mexico Antiparasitics Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mexico Antiparasitics Drugs Market - Competitive Landscape |
10.1 Mexico Antiparasitics Drugs Market Revenue Share, By Companies, 2024 |
10.2 Mexico Antiparasitics Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |